All Activity

Discover the latest generation of new rtg casinos, where classic gaming meets modern features and performance. Powered by RealTime Gaming, these platforms offer hundreds of pokies, table games, and progressive jackpots with smooth gameplay on both desktop and mobile.

The governor of Pennsylvania is using the unofficial cannabis holiday 4/20 to press lawmakers once again to send him a bill to legalize marijuana. Meanwhile, Democratic lawmakers held a hearing focused on the impact of cannabis convictions and the need for legalization. “Pennsylvanians who want to buy recreational marijuana are already driving across the border to one of our neighboring states who’ve legalized it,” Gov. Josh Shapiro (D) said in a social media post on Monday. “That’s hundreds of millions in revenue going out of state instead of being spent here in Pennsylvania.” “It’s time for us to finally catch up—and for the legislature to send a bill to my desk and get this done,” he said. Pennsylvanians who want to buy recreational marijuana are already driving across the border to one of our neighboring states who’ve legalized it. That’s hundreds of millions in revenue going out of state instead of being spent here in Pennsylvania. It’s time for us to finally… pic.twitter.com/ftYLZSpWvD — Governor Josh Shapiro (@GovernorShapiro) April 20, 2026 The push comes days after the House of Representatives passed budget legislation proposed by Shapiro that relies on revenue that would be generated from recreational marijuana sales, which has yet to be legalized in the state. The governor earlier this year included cannabis legalization and the resulting expected revenue in his budget request. The $53.2 billion budget legislation, which doesn’t itself include provisions to actually legalize marijuana even as it contemplates allocating money that would result from it, now heads to the Senate for consideration. Meanwhile on Monday, the House Majority Policy Committee held a hearing on cannabis “clean slate” issues focused on how conviction records have collateral consequences on people’s lives. Members heard from representatives of the Last Prisoner Project, Law Enforcement Action Partnership and Community Legal Services. Rep. Andre Carroll (D) said passing cannabis reform would be “truly transformational” and “have a direct impact” on people across the state. “States that seemingly have nothing else in common, like Mississippi and North Dakota, they have already decriminalized cannabis,” he said. “Yet, Pennsylvania remains one of only 19 states in the country where possession of cannabis is criminal offense, and that carries potential jail time here in our commonwealth.” The Democratic-controlled House of Representatives last year passed a bill to legalize marijuana and put sales in state-owned dispensaries, but the Republican Senate majority has criticized that plan while also not advancing a cannabis legalization model of its own. Rep. Darisha Parker (D) said at Monday’s event that “we did our part here in the House, but the Senate is still falling on the job.” Legalize Adult-Use Cannabis // MAJORITY POLICY POINT pic.twitter.com/E8mrjQnF1r — Pennsylvania House Majority Policy Committee (@PADemPolicy) April 20, 2026 Pennsylvania House Democrats also promoted an online petition on Monday that allows people to easily contact their state senators in support of marijuana legalization legislation. Pennsylvania is moving forward. Legalizing adult-use cannabis means new revenue for our communities and a safer, regulated market. Tell @pasenategop that it’s time to legalize adult-use cannabis in PA: https://t.co/G0eTwfwfs2#legalizepa #cannabis #legalizemarijuana pic.twitter.com/fNWgfY0UnR — PA House Democrats (@PaHouseDems) April 20, 2026 Earlier this month, the House Health Committee approved a bill to allow terminally ill patients to use medical cannabis in hospitals and other healthcare facilities The legislative developments come as a new poll shows that seven out of ten Pennsylvania likely voters support legalizing adult-use marijuana—including majority backing for the reform across party lines. When asked whether they “support or oppose the regulation and taxation of legal cannabis for use by adults 21 and older in Pennsylvania,” 69 percent of respondents said yes. Support was strongest from Democrats, at 72 percent, but also includes 67 percent of Republicans and 64 percent of independents. Meanwhile, Shapiro continuing to pressure on lawmakers to send him a bill to legalize marijuana in the state, saying that doing so would generate new revenue that could be invested in key programs. “While some in Harrisburg claim we can’t afford to make bigger investments in our kids, public safety, and our economy, know this: If we legalized and regulated adult-use cannabis, we’d bring in $1.3 BILLION in revenue for our Commonwealth over the first five years,” the governor said in another recent social media post. “Those are dollars that can be invested back into our people and our communities,” he said. “Stop with the excuses. Let’s get this done.” The state’s Independent Fiscal Office (IFO) reported in February that legalizing cannabis in Pennsylvania would generate nearly half a billion dollars in annual revenue by 2028, an estimate that is a significantly larger cash windfall compared to projections from Shapiro’s own office. With a proposed 20 percent wholesale cannabis excise tax, 6 percent state sales tax for retail and licensing fees, IFO said the governor’s legalization plan would generate $140 million in tax revenue in the first year of implementation from 2027-2028 and increase to $432 million by 2030-2031. That’s a much higher revenue estimate than what the governor’s office put forward in the latest executive budget. According to his office’s analysis, legalization would generate about $36.9 million in tax dollars in its first year from a 20 percent wholesale tax on marijuana—rising gradually to $223.8 million by 2030-2031. In February, a coalition of drug policy and civil liberties organizations urged Shapiro to play a leadership role in convening legislative leaders to get the job done on cannabis legalization this session. Last month, the Senate Law and Justice Committee amended and approved a bill to create a Cannabis Control Board (CCB) to oversee the state’s medical marijuana program and intoxicating hemp products and that could eventually regulate adult-use cannabis if it is legalized in the state. The post Pennsylvania Governor Pushes Lawmakers To Legalize Marijuana On 4/20 appeared first on Marijuana Moment. View the live link on MarijuanaMoment.net

“We’re all very interested in any research on cannabis and safety or its impact on the human body… We’re interested in health research, but it’s not limited to that.” By Rebecca Rivas, Missouri Independent Missouri is preparing to open up an unlimited number of licenses to allow for marijuana research in the state. The Missouri Division of Cannabis Regulation has filed proposed rules with the secretary of state that describe what a research licensee would be authorized to do and outlines the application requirements and process for a marijuana research license. “Ultimately, it’s just exciting to make progress on marijuana research because we know that that’s been historically difficult,” said Rieka Yu, policy director for the division, which is housed within the Missouri Department of Health and Senior Services. The proposed rules will be published in the May 1 issue of the Missouri Register on the Secretary of State’s website, and the public will be able to provide feedback until May 31. When voters approved recreational marijuana in 2022, the constitutional amendment allowed the state to establish licenses to “facilitate scientific research or education.” The language leaves the door open for many research possibilities, said Amy Moore, the division’s director. “We’re all very interested in any research on cannabis and safety or its impact on the human body,” Moore said. “Certainly as a public health agency, we’re interested in health research, but it’s not limited to that. So it’ll be interesting to see what people want to propose once we get this established.” Yu is also interested in research on cultivation. New York passed marijuana rules to allow for research in 2023, and the state has approved studies to look at things like how to protect plants from viruses and how different light impacts plant growth. While the 2022 constitutional amendment allowed for research licenses, Missouri must pass administrative rules to get them off the ground. That process began in August, when the division published a draft of the rules, along with a host of others, asking for informal public feedback. Starting in May, the division will ask for another round of public feedback, in order to file the final version of rules for formal rulemaking this summer. From there, it will take about eight months to get through a legislative review and final publication of the rules. A national study last year found that 17 out of 38 states that have passed either medical or adult-use laws have legislation outlining a funding mechanism for cannabis research. Missouri is not among them. Of the 17 states that have legislation directing funding to research, the study found that 12 have allocated funding. Moore said the division had the option of creating limits or priorities in subject matter for the research studies, but without funding, it may be challenging to attract interest in the licenses. “Letting people decide right now seems advisable, since we’re just not seeing a lot of uptake in other states,” Moore said. “There’s just a lot of challenges still to getting this done.” This story was first published by Missouri Independent. The post Missouri Officials File Rules To Create New Marijuana Research Licenses appeared first on Marijuana Moment. View the live link on MarijuanaMoment.net

April 20, or 4/20, is the unofficial cannabis holiday. And as legalization gains support and marijuana becomes more mainstream, a growing number of elected officials and companies are embracing cannabis culture. Here’s a look at the politicians and brands that are marking 4/20 this year: Politicians And Political Parties No one should go to jail for smoking weed. — Democrats (@TheDemocrats) April 20, 2026 Pennsylvanians who want to buy recreational marijuana are already driving across the border to one of our neighboring states who’ve legalized it. That’s hundreds of millions in revenue going out of state instead of being spent here in Pennsylvania. It’s time for us to finally… pic.twitter.com/ftYLZSpWvD — Governor Josh Shapiro (@GovernorShapiro) April 20, 2026 This year marks 10 years since Californians voted to legalize cannabis. In the decade since, we've expanded opportunity and started to correct past injustices, and we continue building a safer, more accountable system. https://t.co/k3z4DgXsEv — Governor Gavin Newsom (@CAgovernor) April 20, 2026 Happy 4/20, fellow kids pic.twitter.com/OfHQ6L0dYy — Governor Hochul Press Office (@NYGovPress) April 20, 2026 Medical cannabis is bringing relief to Kentuckians; it's also bringing in new business and good jobs. Today we cut the ribbon on Blügrass in Nicholasville, a Kentucky-founded company that has returned to its home state thanks to the legalization of medical cannabis. pic.twitter.com/7yHXWH2gQo — Governor Andy Beshear (@GovAndyBeshear) April 20, 2026 We know what day it is. If you’re celebrating, do it responsibly—don’t drive impaired. Plan a safe ride and look out for each other, Colorado. pic.twitter.com/WNN7PRHatJ — Governor Jared Polis (@GovofCO) April 20, 2026 This 4/20, remember, a blue trifecta in Wisconsin is a huge step towards legalization. pic.twitter.com/fM16zwPZie — Wisconsin Democrats (@WisDems) April 20, 2026 Minnesota and countless other states have proven how we can safely decriminalize and regulate the cannabis industry. Long overdue for the federal government to take a page out of that playbook. — Tina Smith (@SenTinaSmith) April 20, 2026 Best 4/20 meme Best Rubio meme https://t.co/kCG24X7Qkh pic.twitter.com/y9xICirrrJ — Mike Lee (@BasedMikeLee) April 20, 2026 I'm celebrating 420 by calling on Congress to pass my bill, the MORE Act, to end the criminalization of cannabis and correct the historical injustices of failed drug policies. For too long, cannabis policy has been a patchwork of inconsistent state laws that have… pic.twitter.com/TCvTJEG8Xj — Rep. Nadler (@RepJerryNadler) April 20, 2026 This 4/20, let’s recommit to fighting for equitable cannabis reform. Access to capital remains one of the biggest barriers to entry and to success in the cannabis industry. The CLIMB Act will address real-world, operational issues facing the cannabis industry and help open the… pic.twitter.com/zMBme6DxGk — Congressman Troy A. Carter (@RepTroyCarter) April 20, 2026 From skincare to beverages, there’s a hemp-product for everyone. This 4/20, remember to support your local hemp growers, brewers and small business owners! Meanwhile, I’ll keep fighting to reverse the federal hemp ban. — Angie Craig (@RepAngieCraig) April 20, 2026 On this 4/20, even with legalization in sight, there are still tens of thousands of people in prison for nonviolent cannabis “crimes.” Legalization isn’t enough. Everyone caught up in prohibition deserves freedom and a clean record. pic.twitter.com/Ea4DYjen37 — Graham Platner for Senate (@grahamformaine) April 20, 2026 It’s about time Wisconsin legalizes marijuana. Illinois got $36 million dollars in tax revenue from Wisconsinites in one year – we are giving our neighbors millions every year by not legalizing. Happy 4/20, please enjoy responsibly! — Mandela Barnes (@TheOtherMandela) April 20, 2026 Patients with chronic pain. Veterans dealing with PTSD. Families watching a loved one fight cancer. These are the people who voted. These are the people still waiting. — Dan Osborn (@osbornforne) April 20, 2026 I will go to Washington and fight to make sure the federal government respects what Nebraska voters decided. Patients and caregivers are suffering. I will stop the obstruction. — Dan Osborn (@osbornforne) April 20, 2026 We need a smarter approach to marijuana policy. Legalize medical use. Pardon non-violent charges. Let the people decide recreational use through a statewide referendum. Compassion. Fairness. Accountability.https://t.co/gWBw9vMJ3w pic.twitter.com/7A9n4reVSS — Jermaine Johnson (@Dr_JLJohnson) April 20, 2026 Legalize Weed — Zach Wahls (@ZachWahls) April 20, 2026 It's 4/20 and you know what that means… It's time for a new episode of the World's Greatest Audit Podcast. This one features a discussion on the audit of Missouri's Marijuana Program, which found Missouri's multi-billion dollar marijuana industry was launched using a flawed… pic.twitter.com/wWRbMxC5h6 — Auditor Scott Fitzpatrick (@Auditor_Fitz) April 20, 2026 Happy 4/20 to those who observe! Minneapolis’ cannabis legislation rollout is unfolding like a flower in bloom. We’re working to ensure small businesses and events have what they need to succeed—because local entrepreneurs should be at the forefront of this new industry. — Mayor Jacob Frey (@MayorFrey) April 20, 2026 Federal And State Government Agencies "We'ed" like to be blunt: driving high is illegal in all 50 states and DC — on 420 Day and EVERY day. pic.twitter.com/4GL4BctPQ8 — nhtsagov (@NHTSAgov) April 20, 2026 It’s 4/20! Remember to “Make a Plan” if you choose to consume cannabis outside the home or participate in a cannabis-centric social gathering today. Drop the keys, stay put, and plan to use public transportation or catch a sober ride. Visit https://t.co/9rOFhkzg9b for more. pic.twitter.com/kHd1JPDjnu — Massachusetts Cannabis Control Commission (@MA_Cannabis) April 20, 2026 Happy 4/20. If you’re planning to get high, plan not to drive. High driving could lead to high penalties like heavy fines and even jail time. So plan ahead or call a ride. Just don’t drive high. Learn more at https://t.co/m20nJuh5q4. pic.twitter.com/bYkDFN6hWJ — Virginia Cannabis Control Authority (@Virginia_CCA) April 20, 2026 This 420 breathe easy. If you use cannabis, explore non-smoking/non-vaping options. Visit https://t.co/nY5S33f3um to find a legal dispensary. pic.twitter.com/HczqhfwQkC — New Jersey Cannabis Regulatory Commission (@NewJerseyCRC) April 20, 2026 4/20 and the munchies often go hand in hand. Cannabis can heighten taste, smell, and appetite—making food feel more intense than usual. Understanding these effects is part of consuming responsibly. Explore the Cannabis Education Library to stay informed:… pic.twitter.com/cE0ckkQTZ3 — NYS Office of Cannabis Management (@nys_cannabis) April 20, 2026 This 4/20, keep it cute… and keep it locked. We’re giving away lockbags to help you store your #NYCannabis safely—out of sight and out of reach. Want to enter? Tell us how you practice safe storage for your cannabis products: https://t.co/QxDtttT9Ps pic.twitter.com/ktccumS1zg — NYS Office of Cannabis Management (@nys_cannabis) April 20, 2026 Companies And Brands 'Marijuana' is the only English word in which the 'j' is silent. — Merriam-Webster (@MerriamWebster) April 20, 2026 How did “420” become associated with marijuana? pic.twitter.com/oT6hMp1Noi — Encyclopaedia Britannica (@Britannica) April 20, 2026 BYOB $4.20 all day in app for MyRewards members. blaze it. — Carl’s Jr. (@CarlsJr) April 20, 2026 celebrate the toastiest holiday with this dreamy deal get your BOGO Dream Rotation Meal today only 4.20.26 pic.twitter.com/KML1QHpzr7 — Jimmy John’s (@jimmyjohns) April 20, 2026 what u using this for on 4/20? pic.twitter.com/ffOCx2b4sh — Wingstop (@wingstop) April 19, 2026 You know why you're here – $25.99 online only.https://t.co/7UEinCTpYM pic.twitter.com/bb0sZQsywp — Blaze Pizza (@BlazePizza) April 20, 2026 The post Politicians And Major Brands Celebrate Cannabis Culture On 4/20 appeared first on Marijuana Moment. View the live link on MarijuanaMoment.net

A key congressional committee is expected to issue a directive this week for federal agencies to study the “adequacy” of state marijuana laws and to assess methods for “preventing diversion of state legal cannabis product into jurisdictions that do not permit the use of cannabis.” The House Appropriations Committee on Tuesday is scheduled to take up spending legislation and related reports, one of which contains the marijuana provisions. The draft report set to be attached to the Fiscal Year 2027 Financial Services and General Government (FSGG) bill says the panel “recognizes that over 20 States and territories now permit the adult use cannabis, while over 35 States and territories permit the use of cannabis for medicinal purposes.” It directs the Treasury Department’s Alcohol and Tobacco Tax and Trade Bureau (TTB) to “coordinate an assessment of the adequacy of State marijuana regulatory frameworks, including commonalities and novel approaches to enforcement and oversight.” The committee has approved similar cannabis provisions in past years, but it’s not clear if TTB has ever filed a resulting marijuana policy report with lawmakers. Here’s the full language of the current directive set to be approved by the committee this week: “Cannabis Regulatory Framework.—The Committee recognizes that over 20 States and territories now permit the adult use cannabis, while over 35 States and territories permit the use of cannabis for medicinal purposes. The Committee directs TTB in coordination with the entire Department, and other agencies, which may have relevant regulatory expertise, to coordinate an assessment of the adequacy of State marijuana regulatory frameworks, including commonalities and novel approaches to enforcement and oversight. The assessment shall include recommendations to improve data sharing and coordination between State and Federal authorities. The Department is directed brief the Committee on the findings of the assessment within one year of enactment of this Act.” This year’s report also includes a new cannabis-related passage directing TTB and other agencies to assess ways to prevent diversion of marijuana from legal markets to states that maintain prohibition. It reads: “Diversion Prevention.—The Committee urges DOJ, in coordination with the broader Department, TTB, and other agencies that may have relevant regulatory expertise, to coordinate an assessment of the most effective methods of preventing diversion of state legal cannabis product into jurisdictions that do not permit the use of cannabis.” The directive for federal agencies to study the adequacy of state cannabis laws mirrors what was included in reports attached to appropriations bills covering FSGG and Commerce, Justice, Science, and Related Agencies (CJS) in several prior sessions. It is also similar in intent to a standalone bill from House FSGG Appropriations Subcommittee Chairman Dave Joyce (R-OH), co-chair of the Congressional Cannabis Caucus. That legislation would lay the groundwork for federal marijuana legalization, directing the attorney general to create a commission charged with making recommendations on a regulatory system for cannabis. The underlying FSGG bill, meanwhile, includes a longstanding provision continuing to block Washington, D.C. from legalizing and regulating recreational marijuana sales. While local lawmakers have found ways to work around that policy to some extent by significantly expanding access to an existing medical marijuana program, advocates view the rider—championed by prohibitionist Rep. Andy Harris (R-MD)—as a troubling infringement on D.C.’s autonomy. “SEC. 809. (a) None of the Federal funds contained in this Act may be used to enact or carry out any law, rule, or regulation to legalize or otherwise reduce penalties associated with the possession, use, or distribution of any Schedule I substance under the Controlled Substances Act (21 U.S.C. 801 et seq.) or any tetrahydrocannabinols derivative. (b) No funds available for obligation or expenditure by the District of Columbia government under any authority may be used to enact any law, rule, or regulation to legalize or otherwise reduce penalties associated with the possession, use, or distribution of any Schedule I substance under the Controlled Substances Act (21 U.S.C 801 et seq.) or any tetrahydrocannabinols derivative for recreational purposes.” The White House last year called the District’s move to enact local marijuana reform an example of a “failed” policy that “opened the door to disorder.” President Donald Trump’s budget request that he released earlier this month similarly proposed to continue the Harris rider preventing adult-use marijuana sales in D.C. — Marijuana Moment is tracking hundreds of cannabis, psychedelics and drug policy bills in state legislatures and Congress this year. Patreon supporters pledging at least $25/month get access to our interactive maps, charts and hearing calendar so they don’t miss any developments. Learn more about our marijuana bill tracker and become a supporter on Patreon to get access. — Meanwhile on Capitol Hill, bipartisan lawmakers have filed several pieces of legislation to delay or reverse the broad federal recriminalization of hemp THC products that is set to take effect in November. Trump in December directed the Department of Justice to complete the process of moving marijuana from Schedule I of the Controlled Substances Act to Schedule III “in the most expeditious manner,” but that has not yet occurred. The post Federal Agencies Would Have To Study State Marijuana Laws Under New Directive From Congressional Committee appeared first on Marijuana Moment. View the live link on MarijuanaMoment.net

California should ease up on taxes for marijuana businesses like the one they own together, Woody Harrelson and Bill Maher say. The actor and comedian jointly complained about the state’s harsh cannabis taxes in a podcast interview released on Monday, known as the unofficial marijuana holiday 4/20. “California sucks as far as—look, all businesses, but certainly this one,” Maher said on the episode of his Club Random podcast. “They still treat it like it’s poison.” Harrelson agreed, saying, “They treat it like you’re lucky that we allow you to do this, and so we’re going to tax you 35 percent, which is way more—it’s more than double anything.” “I don’t even know what’s the second” in terms of highly taxed items, the actor said, citing guns and beer as facing lower rates than cannabis. “It’s ridiculous that they can just tax the fuck out of you and make it so hard,” he said. “Anyway, I don’t want to bitch and moan. I’m a happy person, generally.” But Maher said, “I’m not happy about this.” “I’m never happy when anybody fucks with my money,” he said. “I’m gangster like that.” Harrelson and Maher own The Woods, a dispensary and cannabis consumption lounge in West Hollywood, where the two smoked joints while filming the new podcast episode. In California, cannabis faces a 15 percent state excise at the point of purchase, as well as local excise taxes that vary from jurisdiction to jurisdiction. There are also regular state and local sales taxes that apply, plus taxes at other points of the supply chain such as at the cultivation level. Marijuana businesses can additionally face steep licensing fees in order to do business. Harrelson further complained during the interview with Maher that “they also don’t allow you to write anything off,” an apparent reference to the federal provision known as 280E that blocks marijuana companies from taking tax deductions that are available to businesses in other sectors. California lawmakers, however, like those in a number of other legal cannabis jurisdictions, have taken steps to decouple the state tax code from the federal policy, allowing operators to write off business expenses on their state taxes. Maher, for his part, also noted the cannabis industry’s banking access issues. “For the longest time, it was a very risky business because you couldn’t put the money in the bank, right?” he said. “The banks wouldn’t take ‘your dirty fucking pot money that you fucking hippies got by smoking pot.'” “And everybody would have truckloads of cash around,” Maher said. “So of course, they were a target for robbers.” To that point, Harrelson and Maher’s dispensary was burglarized in what appeared to be part of a string of crimes targeting cannabis businesses in the region. While the situation is changing and more banks are taking on cannabis clients, as the two noted in the new interview, federal legislation to provide a broad fix for the issue has remained stalled for years. Maher and Harrelson have long publicly embraced their cannabis consumption. Last year, when Harrelson was asked to pick anyone living or dead he would like to patronize the dispensary’s cannabis cafe, he zeroed in on marijuana icon Bob Marley. But the actor also conceded that he doesn’t think he could go “toke-for-toke” with the late reggae star. The actor also got involved in marijuana reform advocacy in California, calling on Gov. Gavin Newsom (D) to sign a bill legalizing marijuana cafes that passed in 2024, which he did end up approving. Earlier this year, Harrelson joked about his experiences getting kicked out of two bars for smoking marijuana indoors with the mother of fellow star Matthew McConaughey. Harrelson separately disclosed in 2017 that used cannabis to help get through a dinner with President Donald Trump. Last year, Maher said he didn’t get high before attending a dinner with Trump at the White House, joking that it was a “missed opportunity.” Image element courtesy of Angela George. The post Woody Harrelson And Bill Maher Complain That Marijuana Taxes Are Too High While Smoking Joints At The Dispensary They Own Together appeared first on Marijuana Moment. View the live link on MarijuanaMoment.net

Delaware lawmakers have passed a bill to let terminally ill patients use medical cannabis in hospitals, sending the measure to the governor. About a month after the cannabis proposal from Sen. Marie Pinkney (D) advanced through the Senate in a unanimous vote, the House of Representatives approved it with a 38-0 tally on Thursday. The measure now heads to Gov. Matt Meyer (D), who can sign, veto or allow it to become law without his signature. Rep. Kamela Smith (D), who carried the legislation in the House, said ahead of the final vote that the bill “is about compassionate, safe and transparent care for the seriously ill.” “This is a patient safety bill. The stigma surrounding cannabis use continues to create unnecessary barriers to patients that are already facing some of the most difficult moments in their life,” she said. “Healthcare facilities will permit use on their premises, but only within established guidelines and safeguards. “Patients are already using it, especially for cancer, chronic pain and serious illness,” Smith said. “Patients shouldn’t have to choose between following their doctor’s treatment plan and following the hospital’s rules and protocols. When patients are admitted to a hospital, their medications are reviewed, the treatment continues, and their plan is managed. Medical marijuana should be treated the same way—openly, safely and not hidden.” If the reform is enacted into law, patients and their caregivers would be responsible for acquiring and administering medical marijuana, and it would need to be stored securely at all times in a locked container. Smoking or vaping of medical cannabis would be prohibited, so patients would need to consume it via other methods. Healthcare facility officials would need to see a copy of patients’ state medical marijuana registry ID cards, and they would be required to note their use of the drug in medical records. They would also need to “develop and disseminate written policies and procedures for the use of medical marijuana within the health care facility.” Facilities would be able to prohibit medical marijuana use if they determine that such use would have an “adverse impact on the medical care and treatment of the patient or is otherwise contraindicated.” They would also be able to suspend permission to use cannabis if a federal agency such as the U.S. Department of Justice or Centers for Medicare and Medicaid Services takes an enforcement action against such use or “issues a rule, guidance, or otherwise provides notification to health care facilities that expressly prohibits the use of medical marijuana in health care facilities.” The right to use medical cannabis under the bill, SB 226, would not apply to patients who are in the emergency department. — Marijuana Moment is tracking hundreds of cannabis, psychedelics and drug policy bills in state legislatures and Congress this year. Patreon supporters pledging at least $25/month get access to our interactive maps, charts and hearing calendar so they don’t miss any developments. Learn more about our marijuana bill tracker and become a supporter on Patreon to get access. — Meanwhile in Delaware, the Senate in January voted to override the governor’s veto of a bill that would prevent local governments from imposing onerous zoning restrictions that make it more challenging for marijuana businesses to operate in their jurisdictions. Delaware’s adult-use cannabis market launched last August, with the governor touting the state’s first “successful” weekend of adult-use cannabis sales, with total purchases for medical and recreational marijuana totaling nearly $1 million—and compliance checks demonstrating that the regulated market is operating as intended under the law. The launch of Delaware’s legal market came about two years after marijuana legalization was enacted into law under former Gov. John Carney (D). Ahead of the sales roll-out, the governor last July toured one of the state’s cannabis cultivation facilities, praising the quality of marijuana that’s being produced, which he said will be the “French wine of weed.” The launch of the legal market came with some controversy, however, with critics alleging that allowing medical operators to start adult-use sales ahead of other license applicants is unfair. Dozens of other would-be retailers that have either already received licenses or are still awaiting issuance will need to wait for further regulatory approvals until they can open their doors—a situation that’s frustrated some advocates. Two lawmakers who led the push to legalize marijuana sought input from consumers and businesses about the market launch. Sen. Trey Paradee (D), the sponsor of SB 75, and House Majority Whip Rep. Ed Osienski (D)—the primary sponsor of the state’s 2023 legalization bills—put out an online form last year for residents to share thoughts and feedback about the cannabis program anonymously. Separately, a Delaware House committee in January approved a bill to decriminalize public consumption of marijuana. While certain legal marijuana states like Colorado and Ohio still impose criminal penalties for public cannabis use, Delaware stands out as especially punitive, with a maximum penalty that carries the risk of jail time in addition to a fine. Photo courtesy of Max Pixel. The post Delaware Lawmakers Pass Bill To Allow Medical Marijuana Use In Hospitals For Terminally Ill Patients, Sending It To Governor appeared first on Marijuana Moment. View the live link on MarijuanaMoment.net

As more states pass laws legalizing marijuana, arrests for cannabis are dropping considerably, a new report from an advocacy organization shows, not surprisingly. But it also makes the case that there is still work to be done as tens of thousands of people continue to be put in handcuffs every year in the U.S. over something that is now legal in nearly half the states. Using data from the Federal Bureau of Investigation (FBI), the new Marijuana Policy Project (MPP) analysis tracks cannabis enforcement trends in states that have enacted reform and those that have not—showing a “wide gap between legalization and prohibition states,” according to the group’s press release. “With cannabis legal and regulated, we anticipated that arrest rates for possession, manufacturing, and sales would plummet as demand shifted to the legal, regulated market,” the report says. “The data backs that up.” The group released the report on Monday, known as the unofficial cannabis holiday 4/20. It shows that there have been more than 21 million cannabis arrests in the U.S. since 1995, but that the trend is very much on the decline as more legalization laws come online. “Annual cannabis arrests in the United States (including the District of Columbia and U.S. territories) have dropped from a peak of over 870,000 in 2007 to 211,104 in 2025,” MPP said. “Cannabis arrests dropped in every state after legalization. On average, legalization states’ cannabis arrest rates have dropped 85.53%, with possession arrests dropping by an average of 84.61% and sales arrests decreasing by an average of 80.39%.” The 24 states with marijuana legalization laws on the books “made a total of 222,261 fewer cannabis arrests in 2025 than they did the year prior to their legalization of cannabis,” the report found. In contrast, states that maintain prohibition made “more than eight times as many cannabis arrests than legalization states in 2025, although they have a smaller total population.” Last year alone, police in legalization states made 22,357 cannabis arrests, compared to 186,581 marijuana arrests in prohibition states. Adam Smith, MPP’s executive director, said in a press release that “cannabis legalization across 24 states has driven a historic decline in cannabis arrests nationwide, from a high of more than 900,000 to just over 200,000 annually.” “That is still an alarmingly high number, with each of those arrests representing an actual person whose current reality and future prospects may well be derailed by a criminal record,” he said. “Across half of our country, hundreds of thousands of Americans are still being funneled into the criminal justice system every year for a victimless ‘crime’ that is very likely legal in the next state over.” Prior to publishing the report, MPP put out a call for supporters to share their stories about being arrested for marijuana—and the resulting document includes several profiles of people who have had their lives upended due to cannabis-related law enforcement encounters. One such story reads: “I was arrested and locked in a cage on my 19th birthday for $20 worth of cannabis. I was jailed with other inmates charged with aggravated assault and armed robbery. I spent 23 days incarcerated for a victimless crime, $1,000 in court fines and fees, $2,200 in attorney costs, $600 in court-ordered probationary classes, and drug screenings. It almost derailed my college career. The trauma I experienced haunts me to this day.” Another says: “I am a disabled mother and grandmother with progressive genetic neuropathy who was able to stop using opiates thanks to cannabis. I was stopped for a rolling stop. The officer said he smelled marijuana and threatened to call the K9. I gave them the small bud (one gram) and pipe I had. Because I refused to plea or inform on others, I was thrown in jail in an overcrowded condemned jail to sleep on the floor for 46 days with no working toilet. My charges were eventually dropped, but I still have PTSD from my time in jail. I am unable to get my driver’s license due to all the fines and fees imposed on me. I live in constant fear that the police are going to break down my door and arrest me because of my choice of medicine.” MPP notes that while legalization has driven a large-scale reduction in the number of arrests, “22,357 total cannabis arrests in a single year is still an alarmingly large number.” “Arrests can be traumatic and incarceration is even more so. A day of missed work due to an arrest can result in job loss, which can result in lost housing and homelessness,” the report says. “Americans have even died while incarcerated for cannabis possession. Longer term, criminal records create barriers to housing, employment, and professional and occupational licensing.” Even in states that have legalized cannabis, MPP notes, some still prohibit home cultivation or administer harsh criminal penalties for consuming marijuana in public or for possession by people under the age of 21. “While we are not aware of any state that limits how much beer or wine an adult can possess, every legalization state caps the amount of cannabis adults can possess. Some limits are as low as one ounce,” it notes. “Although legalization states have dramatically reduced their number of arrests for marijuana, many still have significant work to do to stop ruining lives over personal use, possession, and cultivation of cannabis.” Data released by FBI late last year show that of all drug possession arrests in the country, 27 percent were for marijuana—more than for any other specifically listed substance. An separate analysis of the data by the National Organization for the Reform of Marijuana Laws (NORML) concluded that marijuana arrests are driving the overall war on drugs in states where cannabis remains illegal. The organization focused on 14 states in particular. In five of those states (Idaho, Iowa, Louisiana, Nebraska and Wisconsin), marijuana accounted for more than 50 percent of total drug-related arrests last year. For the other nine states (Alabama, Georgia, Indiana, Kansas, Mississippi, North Dakota, South Carolina, Utah and Wyoming), cannabis constituted a plurality of more than 40 percent of drug-related arrests. Notably, the FBI data, which are compiled from submissions to the agency by local and state law enforcement, show that more than 97 percent of cannabis arrests in Alabama, Nebraska, North Dakota, South Dakota, Texas, Utah and Wyoming were over possession, rather than trafficking or sales. NORML, meanwhile, recently launched a survey asking cannabis consumers about the freedoms (or lack thereof) that they experience where they live. The survey is “designed to capture real-time sentiment from cannabis consumers across the United States and beyond, offering a snapshot of how individuals experience cannabis policy in their daily lives,” the group said. The post New Marijuana Report Shows Arrests Are Plummeting As Legalization Spreads, But Criminalized States Still Send Thousands To Jail Each Year appeared first on Marijuana Moment. View the live link on MarijuanaMoment.net

We present you with outstanding, lovely Kirti Nagar Escorts that every man wishes to have as partners. You'll attract attention and admiration from others whenever they're around you with our stunning beauties. Moreover, these courtesans will satisfy your masculine cravings, regardless of how profound or illicit your needs may be. Employing these ladies will provide you with more than anticipated from your ideal partner.

Trump on psychedelics & marijuana rescheduling; New hemp bill lets states opt out of ban; TX cannabis poll; Study: Marijuana as sub for Rx drugs Subscribe to receive Marijuana Moment’s newsletter in your inbox every weekday morning. It’s the best way to make sure you know which cannabis stories are shaping the day. Get our daily newsletter. Email address: Leave this field empty if you're human: Your support makes Marijuana Moment possible… Free to read (but not free to produce)! We’re proud of our newsletter and the reporting we publish at Marijuana Moment, and we’re happy to provide it for free. But it takes a lot of work and resources to make this happen. If you value Marijuana Moment, invest in our success on Patreon so we can expand our coverage and more readers can benefit: https://www.patreon.com/marijuanamoment / TOP THINGS TO KNOW President Donald Trump signed an executive order aimed at boosting research on and expanding legal access to psychedelics such as psilocybin, ibogaine and MDMA for people struggling with mental health conditions. It will “facilitate fast rescheduling of any psychedelic drugs that become FDA approved,” he said. President Donald Trump complained that the Department of Justice is “slow-walking” following through on rescheduling marijuana under an executive order he issued four months ago. “Will you get the rescheduling done, please?” A wide range of lawmakers, officials and celebrities—from Sen. Lindsey Graham (R-SC) to California Gov. Gavin Newsom (D) to rapper Nicki Minaj—are praising President Donald Trump’s psychedelics executive order. Sens. Rand Paul (R-KY), Amy Klobuchar (D-MN) and Joni Ernst (R-IA) filed a bill to let states and Indian tribes opt out of the federal recriminalization of hemp THC products that’s set to take effect in November. Sen. Cory Booker (D-NJ) joked that cannabis is safer than McDonald’s french fries—saying that “I am the leader in the Senate for descheduling marijuana, but we should schedule McDonald’s french fries.” “I don’t know what they put on them. I think it is an illegal substance.” The Louisiana Senate passed a bill to create a psychedelic-assisted therapy pilot program, using opioid settlement dollars to fund clinical trials aimed at developing alternative treatments such as psilocybin and ibogaine. A new poll shows that 75 percent of Texas voters support legal medical marijuana—including majorities of Democrats, Republicans and independents—but that they are largely unaware of the state’s existing program that provides limited access to cannabis for certain patients. A new study of more than 3,500 patients found that “through the use of medical cannabis, patients were able to reduce the use of other prescription medications by an average of 84.5% across all categories”—including opioids, sleeping aids and antidepressants. “60.7% of patients report no longer experiencing medication-associated side effects due to the use of medical cannabis.” An Ohio judge issued a temporary restraining order preventing the enforcement of the state’s new intoxicating hemp THC product ban against two specific businesses. A New Jersey law restricting the availability of intoxicating hemp THC products to licensed marijuana dispensaries took effect. The Colorado Marijuana Enforcement Division announced a crackdown on companies that illegally sell cheaper and potentially hazardous hemp products as marijuana—citing “serious risks to public safety, market integrity and the tax revenue framework that supports Colorado’s regulated cannabis industry.” / FEDERAL The Drug Enforcement Administration is promoting the inaugural Cannabis Use Disorder Prevention and Awareness Week. Reps. Michael McCaul (R-TX) and Morgan Luttrell (R-TX) sent a letter asking President Donad Trump to “pursue avenues to expand access to ibogaine for our nation’s veterans” days before he issued an executive order on the issue. / STATES Colorado lawmakers filed legislation to put a measure on the November ballot asking voters to overhaul marijuana taxation, testing and other rules. A Virginia senator discussed strategy for addressing Gov. Abigail Spanberger’s (D) amendments to her marijuana sales legalization bill. A Pennsylvania senator said some of his colleagues “in conservative districts that are cautious to support something like adult-use cannabis.” California regulators announced a recall of marijuana products that contain the synthetic cannabinoids THC-O and THCP. Separately, they sent tips about celebrating 4/20 responsibly. Colorado regulators sent a notice about avoiding driving under the influence on 4/20. Illinois regulators adopted changes to medical cannabis rules. Massachusetts regulators voted to freeze the issuance of cannabis cultivation licenses. South Dakota’s medical cannabis patient count increased 62 percent over the past year. New York regulators will host a listening session on marijuana rules on Wednesday. — Marijuana Moment is tracking hundreds of cannabis, psychedelics and drug policy bills in state legislatures and Congress this year. Patreon supporters pledging at least $25/month get access to our interactive maps, charts and hearing calendar so they don’t miss any developments. Learn more about our marijuana bill tracker and become a supporter on Patreon to get access. — / LOCAL Former Chicago, Illinois Mayor Rahm Emanuel (D) sought to pivot away from a marijuana question in an appearance on Bill Maher’s HBO show. The Colorado Springs, Colorado deputy fire chief said revenue from legal marijuana sales “allows us to maintain our staffing levels and ultimately provide a safer community.” / INTERNATIONAL Jamaican regulators launched a revised medical cannabis business licensing system. / SCIENCE & HEALTH A study suggested that “CBD combined with etoposide represents a promising strategy to enhance treatment efficacy in [non-small cell lung cancer]—particularly in tumors retaining p53 function—by concurrently engaging autophagic/lysosomal cell death programs and suppressing oncogenic signaling beyond canonical cannabinoid pathways.” A study found that “a single administration of psilocybin in an open-label context may produce short-term improvements in alcohol use and core predictors of clinical change.” / ADVOCACY, OPINION & ANALYSIS Wine & Spirits Wholesalers of America’s executive vice president of government affairs appeared on a cannabis podcast. / BUSINESS WM Technology, Inc. reported preliminary quarterly revenue in the expected range of approximately $42 million to $44 million. Decibel Cannabis Company Inc. reported quarterly net revenue of C$28.7 million and a net loss and comprehensive loss of C$1.3 million. SHF Holdings, Inc., d/b/a Safe Harbor Financial reported quarterly revenue of $2.1 million and a net loss of $0.6 million. Missouri retailers sold $131.1 million worth of legal marijuana products in March. / CULTURE Snoop Dogg and Xzibit are opening additional marijuana dispensary locations in California. Make sure to subscribe to get Marijuana Moment’s daily dispatch in your inbox. Get our daily newsletter. Email address: Leave this field empty if you're human: Photo courtesy of Chris Wallis // Side Pocket Images. The post Cannabis is safer than McDonald’s, senator says (Newsletter: April 20, 2026) appeared first on Marijuana Moment. View the live link on MarijuanaMoment.net

What a fantabulous post this has been. Never seen this kind of useful post. I am grateful to you and expect more number of posts like these. Thank you very much. exodus download

The governor of Massachusetts has signed a bill to double the legal marijuana possession limit for adults and revise the regulatory framework for the state’s adult-use cannabis market. Gov. Maura Healey (D) approved the legislation on Sunday, about a week and a half after lawmakers sent it to her desk in unanimous House and Senate votes. “The cannabis industry is an important part of Massachusetts economy—supporting jobs and local businesses and generating revenue for cities and towns,” Healey said in a press release. “It’s important that we are doing everything we can to make sure this industry is set up for success and that we remain competitive in this fast-growing market. I’m grateful to the Legislature for their leadership on this critical reform bill.” A bicameral conference committee had spent months working out provisions of the legislation after both chambers passed differing versions last year, and the panel approved a compromise approach on Monday. “With the governor’s signature today our legislature takes an important step in making the cannabis industry here in Massachusetts more responsive, profitable, and competitive for business owners and consumers,” Sen. Adam Gómez (D), who co-chaired the bicameral panel, said . “This legislation strengthens oversight of the Cannabis Control Commission, making smart updates that support small businesses, improve accountability, and ensure consumers can access cannabis safely and legally.” “Through clarifying delivery and advertising rules, increasing transparency on accounts receivable, raising purchasing amounts, and modernizing license caps, we are building a more stable and equitable cannabis marketplace for our state and I am proud of our body for prioritizing reform this session,” he said. Rep. Daniel M. Donahue (D), who also co-chaired the conference committee and who with Gómez additionally co-chairs the Joint Committee on Cannabis Policy, said he is “thrilled” the legislation has become law. “These reforms signal a renewed commitment from the Commonwealth to ensuring a safe, equitable, and prosperous future for the legalized cannabis industry,” he said. “I look forward to working with the administration through their implementation.” Among the revisions to the state’s cannabis law is a section that increases the personal possession limit for marijuana from one to two ounces. Colorado enacted the same reform in 2021 after that state’s cannabis market matured. H.5350 also reduces the size and revise the organization of the Cannabis Control Commission (CCC), while also updating limits on marijuana business licensing. — Marijuana Moment is tracking hundreds of cannabis, psychedelics and drug policy bills in state legislatures and Congress this year. Patreon supporters pledging at least $25/month get access to our interactive maps, charts and hearing calendar so they don’t miss any developments. Learn more about our marijuana bill tracker and become a supporter on Patreon to get access. — Under both chambers’ versions of the bill, CCC would be comprised of three members rather than the current five. The conference committee report that has now been enacted into law adopts provisions from the House measure that will allow the governor to make all appointments, rather than the Senate approach to give one of the appointments to the attorney general. Under prior law, the treasurer also played a role in appointing commission members, but that will no longer be the case. The proposal requires that one member of CCC to have a background in social justice, while the other two commissioners need to have backgrounds in public health, public safety, social justice, consumer regulations or the production and distribution of cannabis. The new law also increases the amount of licenses that a single entity can possess from three to six, while additionally raising from 10 percent to 20 percent the threshold of much equity in a business is considered ownership for the purpose of counting toward the cap on licenses. It also removes a current requirement that medical cannabis operators be vertically integrated to simultaneously cultivate, manufacture and sell marijuana. It additionally gives regulators the ability to allow dispensaries to advertise sales, discounts and customer loyalty programs inside of retail locations and by opt-in email, and it specifies that marijuana delivery operators can deliver to any municipality unless local officials proactively prohibit cannabis businesses and opt out of delivery. The measure also creates a new portal for reporting illegal conduct and directs regulators to create a list of “delinquent” cannabis businesses that have not paid their debts to other operators for more than 60 days and prevents others from doing business with those on the delinquent list until debts are paid off. The legislation additionally requires regulators to study and report on hemp-derived products, the public health impacts of cannabis, tax policy and workplace safety standards. Ahead of the governor’s signing the bill, CCC published guidance on the new law’s immediate impact. Attention licensees: The Commission has issued a bulletin relative to potential immediate impacts of new cannabis legislation that is on the Governor’s desk for consideration to become law by this Sunday. Learn more: https://t.co/rvLWIp4LkR — Massachusetts Cannabis Control Commission (@MA_Cannabis) April 17, 2026 After the bill was signed on Sunday, CCC Executive Director Travis Ahern said that “during this transition, the organization will remain focused on its primary mission of regulating a safe, equitable cannabis industry for consumers, patients, business leaders and taxpayers in Massachusetts.” The cannabis regulation reform’s enactment comes as marijuana businesses in the state have filed a lawsuit aiming to block an initiative to roll back the state’s voter-approved legalization law from reaching the November ballot. If passed, the state wouldn’t revert back to blanket prohibition; rather, it would repeal the commercial recreational sales and personal home cultivation components of the law while still allowing adults 21 and older to possess up to an ounce of cannabis for personal use. Possession of more than one ounce but less than two ounces would be effectively decriminalized, with violators subject to a $100 fine. Adults could also continue to gift cannabis between each other without remuneration. Medical marijuana sales would remain legal. The measure is currently before the legislature after supporters turned in an initial batch of signatures last year, and lawmakers have until May 5 to act on the proposal. If they choose not to enact it legislatively, the campaign would need to go through another round of petitioning and get at least 12,429 certified signatures by July 1 to make the November ballot. Proponents faced skeptical questioning from lawmakers at a hearing of the Joint Committee on Initiative Petitions last month, with several raising concerns about the motivations behind the anti-marijuana measure and its implications for consumers and businesses. A recent Bay State Poll from the University of Hampshire’s States of Opinion Project found that a majority of Massachusetts adults oppose the marijuana sales and cultivation repeal initiative. Meanwhile, in November, the legislature’s Joint Cannabis Policy Committee advanced a bill that would require a study into legal barriers facing first responders who wish to use marijuana in compliance with state law. Regulators would also need to look into the efficacy of marijuana in the treatment of anxiety, depression and post-traumatic stress disorder (PTSD). They would additionally examine laws and policies for cannabis use by police officers and first responders in other jurisdictions and “any other topics the commission deems relevant.” The bill was reported out as lawmakers in a different committee approved separate legislation to provide employment protections for people who use marijuana. Another panel advanced a similar cannabis employment protections bill in September. Meanwhile, the head of Massachusetts’s marijuana regulatory agency recently suggested that the measure to effectively recriminalize recreational cannabis sales could imperil tax revenue that’s being used to support substance misuse treatment efforts and other public programs. To that point, Massachusetts recently reached another marijuana milestone, with officials announcing in February that the state has surpassed $9 billion in adult-use cannabis purchases since the market launched in 2018. A report from the Cannabis Control Commission (CCC) found that legalization is achieving one of its primary goals: disrupting illicit cannabis sales as adults transition to the regulated market. It shows that among adults who reported past-year marijuana use, an overwhelming 84 percent said they obtained their cannabis from a licensed source. Massachusetts lawmakers also recently assembled a bicameral conference committee to reach a deal on a bill that would double the legal marijuana possession limit for adults and revise the regulatory framework for the state’s adult-use cannabis market. In December, state regulators also finalized rules for marijuana social consumption lounges. CCC recently launched an online platform aimed at helping people find jobs, workplace training and networking opportunities in the state’s legal cannabis industry. Separately, lawmakers are also advancing legislation to establish pilot programs for the regulated therapeutic use of psychedelics. The post Massachusetts Governor Signs Bill Doubling Legal Marijuana Possession Limit And Revising Industry Rules appeared first on Marijuana Moment. View the live link on MarijuanaMoment.net

A wide range of bipartisan lawmakers, federal officials, state leaders, advocacy groups and celebrities are weighing in after President Donald Trump issued an executive order aimed at expanding and expediting research on the potential therapeutic benefits of psychedelics. Here’s a look at what people are saying: Lawmakers Sen. Lindsey Graham (R-SC) Totally support President Trump’s executive order that will allow alternative therapies to be approved by the FDA to treat mental health issues experienced by our veterans and others. This is a very good decision by President Trump. Congratulations to everyone who has been… https://t.co/l01VfZvCjE — Lindsey Graham (@LindseyGrahamSC) April 18, 2026 Sen. Tim Sheehy (R-MT) This is a massive leap forward for veterans’ healthcare. It is long overdue that we open up all available avenues to provide warriors the care they need so that when they return from war – they can carry on life as Veterans, not Victims. I am proud of the coalition we have… https://t.co/SovmMQImF5 — Tim Sheehy (@TimSheehyMT) April 18, 2026 Sen. Dave McCormick (R-PA) The Trump EO clears federal roadblocks by directing HHS and the FDA to work with @deptvetaffairs and the private sector on clinical trials for experimental psychedelic therapies. That’s why I partnered with @SenRubenGallego to introduce S. 4031. Veterans deserve safe,… https://t.co/7Zt2UlU3NU — Senator Dave McCormick (@SenMcCormickPA) April 18, 2026 Rep. Morgan Luttrell (R-TX) Today marks a decisive step forward in our commitment to exploring innovative treatments for the invisible wounds carried by so many of our veterans. I want to thank President Trump for his leadership on this issue and for recognizing the urgency of investing in groundbreaking… pic.twitter.com/p4eQB9H9wW — Congressman Morgan Luttrell (@RepLuttrell) April 18, 2026 .@MarcusLuttrell and I just left the White House. What a massive step forward for our veterans pic.twitter.com/UBjnycEaNR — Congressman Morgan Luttrell (@RepLuttrell) April 18, 2026 Rep. Lou Correa (D-CA) President Trump and I agree on this one. This is good for our veterans. Psychedelics promise to cure PTSD, mental health, alcoholism, drug addiction, Alzheimer’s and other ailments. Is it the magic cure? That’s what it looks like. Let’s find out. First, we need to declassify… — Rep. Lou Correa (@RepLouCorrea) April 18, 2026 Rep. Dan Crenshaw (R-TX) Countless lives could be saved by this. President @realDonaldTrump announced today he’s fast-tracking research into ibogaine and other psychedelic therapies for veterans suffering from PTSD. I’ve seen firsthand what this treatment can do. I have friends who are alive and… pic.twitter.com/Hl2HKSLTyY — Dan Crenshaw (@DanCrenshawTX) April 18, 2026 Rep. Michael McCaul (R-TX) My joint statement with @RepLuttrell on President Trump’s EO expanding access to ibogaine for veterans: “Our veterans and special operators risked everything to defend our freedoms, yet too many return home to a lifetime of devastating pain and trauma. We have a profound moral… https://t.co/rGpJN2WpCY — Michael McCaul (@RepMcCaul) April 18, 2026 Rep. John James (R-MI) I flew combat missions. I have lost brothers, not in the skies over enemy territory, but back home after we returned. The invisible wounds of war do not disappear when the uniform comes off. Huge respect to the veterans, like my friend @RepLuttrell, and other advocates like… https://t.co/XXDyJXxVYz — John James (@JohnJamesMI) April 18, 2026 Rep. Tim Burchett (R-TN) This is what I voted for @realDonaldTrump @POTUS https://t.co/Z1LZ5sFkNu — Tim Burchett (@timburchett) April 18, 2026 Federal Officials Health and Human Services Secretary Robert F. Kennedy Jr. Thanks to the leadership of President Trump, under this historic Executive Order, @HHSGov will accelerate research, approval, and access to new mental health treatments, including psychedelic therapies such as ibogaine. pic.twitter.com/ZiUl5IaoBL — Secretary Kennedy (@SecKennedy) April 18, 2026 These therapies could offer longer-lasting relief, and reduce the economic burden of mental illness, which costs the country hundreds of billions of dollars each year. pic.twitter.com/9QIyrD6OPU — Secretary Kennedy (@SecKennedy) April 18, 2026 Thank you, @joerogan, for helping bring national attention to these potentially life-saving treatments for veterans and others living with mental illness, and for pushing this conversation into the mainstream. pic.twitter.com/GVIF6EEESQ — Secretary Kennedy (@SecKennedy) April 18, 2026 Veterans Affairs Secretary Doug Collins Thank you, President Trump. We need an all-of-the-above strategy when it comes to tackling mental health, and your EO opens up new possibilities for America’s Veterans. https://t.co/OOqKuWd6C2 — VA Secretary Doug Collins (@SecVetAffairs) April 18, 2026 Food and Drug Administration Commissioner Marty Makary FDA is moving proactively to advance potential therapies to address America’s mental health crisis. It’s time for new approaches. pic.twitter.com/quwx4DsquY — Dr. Marty Makary (@DrMakaryFDA) April 18, 2026 President Trump signs executive order to accelerate research into psychedelic therapies for veterans with PTSD. |@DrMakaryFDA pic.twitter.com/VAfTRqNpXq — FOX & Friends (@foxandfriends) April 19, 2026 Centers for Medicare & Medicaid Services Mehmet Oz In a paradigm shift for mental health treatment, President Trump’s Executive Order fast-tracks access to psychedelic treatments for 14 million Americans in need. Momentum matters—credit to @joerogan for reigniting the conversation and to @SecKennedy for driving a… pic.twitter.com/ok0DnAcotV — Dr. Mehmet Oz (@DrOz) April 18, 2026 Director of National Intelligence Tulsi Gabbard Many thanks to President Trump for bringing common sense action to the issue of psychedelics. Too many of my friends I deployed with have come home with invisible wounds and when seeking help, are given bags of prescription drugs by the VA to try to numb the pain, only to make… https://t.co/UfiKCeu42r — Tulsi Gabbard (@TulsiGabbard) April 18, 2026 White House Press Secretary Karoline Leavitt Nobody gets it done like President Trump. https://t.co/otyz2vJM3J — Karoline Leavitt (@PressSec) April 18, 2026 State Officials California Gov. Gavin Newsom (D) California continues to lead the way. Good to see Trump follow @CAGovernor Gavin Newsom’s lead in fast-tracking research into psychedelics with real potential to treat PTSD. https://t.co/4znc5KVb5B pic.twitter.com/vUnruLiq12 — Governor Newsom Press Office (@GovPressOffice) April 18, 2026 Former Texas Gov. Rick Perry (R) “This is a historic moment for our Veterans and for this country. I have seen firsthand the impact ibogaine can have on our warfighters. For too long, they have been forced to leave the United States to access care. That should never have been the case. Today is a major step toward correcting that.” Advocacy Organizations The American Legion "There is hope that these psychedelic drugs will serve as a pathway to and promise of a brighter future for our veterans & their loved ones." Nat'l Cdr Wiley on executive order to accelerate research & improving access to emerging therapies, including certain psychedelic… pic.twitter.com/e4QEkeFGV5 — The American Legion (@AmericanLegion) April 19, 2026 Celebrities Nicki Minaj Game Changer This just saved millions of lives. https://t.co/FAQDl8Bglr — Nicki Minaj (@NICKIMINAJ) April 18, 2026 Photo elements courtesy of carlosemmaskype and Apollo. The post Lawmakers, Officials And Celebs React To Trump’s Psychedelics Executive Order appeared first on Marijuana Moment. View the live link on MarijuanaMoment.net

Your perspective on this topic is both unique and enlightening. pips It took me a little while to read all of the comments, but I found the article to be quite intriguing.

Intoxicating THC products are now only available for legal purchase through licensed marijuana dispensaries. By Phillip Smith, The American Hemp Monitor A bill New Jersey Gov. Mikie Sherill (D) signed into law at the end of last month and which went into effect Monday, Senate Bill 3945, temporarily tightens the regulation of hemp-derived intoxicating cannabinoids before making permanent changes that go into effect on November 13, the same day the pending tightening of federal hemp regulations goes into effect. According to the New Jersey Cannabis Regulatory Commission, as of Monday, the following items are no longer defined as hemp but as marijuana, which is legal in the state: plants or viable seeds from a cannabis plant exceeding more than 0.3 percent total THC (including not just delta-9 THC but also delta-8, delta-10, THCA, and other intoxicating cannabinoids) by dry weight, cannabinoids not capable of being naturally produced by a cannabis plant, cannabinoids capable of being naturally produced but were chemically synthesized and products containing more than 0.4 milligrams of total THC per container. Such products may now be purchased only at licensed marijuana retailers. They had previously been available at gas stations, convenience stores, CBD shops and smoke shops. The new law also bars the sale of any hemp-derived intoxicating products, including beverages, online or via vending machines, sales to people under 21 and the sale of cannabinoids synthesized using a chemical process. Monday’s changes apply to all intoxicating hemp products except hemp beverages, which will be allowed to be sold through a temporary, tightly regulated window under the Division of Alcoholic Beverage Control until November 13. After that date, all intoxicating hemp products exceeding 0.4 milligrams of total THC must be sold only through the state’s licensed marijuana system. The purpose of the limited window for hemp beverages is to allow licensed hemp producers, retailers and regulators the ability to continue operating under temporary rules while regulations to allow the sale of THC-containing hemp products via the marijuana marketplace are sorted out. The Cannabis Regulatory Commission is also warning in-state hemp cultivators who plan to produce products that exceed the April 13 hemp limits to apply for marijuana cultivation or manufacturing licenses because “selling, producing or distributing these products without a license from the Commission will be unlawful after April 13, 2026.” This story was first published by The American Hemp Monitor. The post New Jersey Hemp Product Restrictions Take Effect appeared first on Marijuana Moment. View the live link on MarijuanaMoment.net

You make so many great points here that I read your article a couple of times. Your views are in accordance with my own for the most part. This is great content for your readers. slot online terpercaya

You completed a few fine points there. I did a search on the subject and found nearly all persons will go along with with your blog. slot resmi

These issues “present serious risks to public safety, market integrity and the tax revenue framework that supports Colorado’s regulated cannabis industry.” By Christopher Osher, ProPublica and Evan Wyloge, The Denver Gazette This story was originally published by ProPublica. Colorado regulators announced on Monday that they plan to crack down on companies that illegally sell cheaper and potentially hazardous hemp products as marijuana. The state’s Marijuana Enforcement Division said it had detected “regulatory compliance issues” that threaten to unravel the marijuana industry in the nation’s first legal retail market. These issues “present serious risks to public safety, market integrity and the tax revenue framework that supports Colorado’s regulated cannabis industry,” the agency stated in an industry bulletin. A Denver Gazette and ProPublica investigation in January reported that, despite Colorado being one of the first states to ban the sale of intoxicating hemp products, the legislature and regulators failed to adopt many regulations that other states have employed to keep hemp products off marijuana dispensary shelves. Creating the liquid distillate for vapes and edibles from hemp is much cheaper than using marijuana, giving companies a competitive advantage. But regulators say they’re worried because manufacturers rely on toxic and potentially hazardous chemicals to convert the nonintoxicating compound CBD that is prevalent in hemp into THC, the psychoactive compound that makes people feel high. Regulators have banned such chemical synthesis because they say they fear chemical residues could remain in finished products, imperiling consumers. Colorado manufacturers have exploited gaps in the state’s testing and enforcement system to continue using hemp to make products marketed as marijuana, even though doing so is against state law, according to regulatory investigations, previous agency bulletins and testimony and lab results contained in several lawsuits. In 2024, state investigators found that one popular brand of marijuana vapes sold in dispensaries was not only derived from hemp, but also contaminated with methylene chloride, a chemical often used to convert CBD from hemp into THC. It is prohibited by Colorado’s marijuana regulators and banned for most uses by the U.S. Environmental Protection Agency because it can cause liver and lung cancer and damage the nervous, immune and reproductive systems. Ware Hause, the company that manufactured those vapes, surrendered its marijuana license in response to the investigation. Ware Hause’s owner, Thanh Hau, and the company’s lawyer have declined to comment. Congress passed a law last November banning nearly all intoxicating hemp products throughout the country starting this fall, but it’s unclear how the government will implement that ban, and hemp manufacturers are pushing to overturn it. In December, President Donald Trump issued an executive order telling his aides to work with Congress on developing regulations that could allow some hemp products. Colorado’s Marijuana Enforcement Division announced in the Monday bulletin that agency officials had “identified and investigated evidence” indicating marijuana businesses are using illicit practices and banned methods to manufacture products instead of relying on marijuana, which is supposed to be tracked for safety. The Colorado Hemp Association and the Colorado Hemp Education Association did not immediately respond to requests for comment. Beyond the safety issues, the bulletin also noted that some marijuana manufacturers and cultivators are avoiding marijuana tax obligations through “a pattern of noncompliance” in the sales transactions they report to the state’s “seed-to-sale” tracking system, which follows marijuana from initial planting to the sale of pot, vapes and other products in dispensaries. Companies are misreporting their bulk marijuana sales at nominal prices, in some cases as low as $1 a pound for unprocessed marijuana material, the bulletin stated. Those products typically fetch as much as $600 a pound on the open market, depending on the category of marijuana, according to industry insiders. Such fraudulent reporting has robbed the state and local governments of millions of dollars in marijuana tax revenue, industry insiders say, though there’s no official estimate. The agency said it would pursue emergency rules to address such problems. Suspicious and anomalous transactions and inventories the state detects will prompt investigations, the bulletin stressed. Companies caught using hemp or other illicit material they pass off as marijuana face “immediate product embargo, license suspension or revocation, significant monetary penalties and referral to law enforcement,” the regulators warned. The Denver Gazette and ProPublica have attempted to track anomalous transactions, but the Marijuana Enforcement Division has maintained that the sales transaction records, even those that don’t identify companies, are not public. Marijuana industry representatives met with division regulators late last month to press for a more aggressive response to hemp substitution from the agency, even though it could affect some companies in the industry. The representatives argued that bad actors are unfairly driving down prices and shifting the tax burden to manufacturers and cultivators who are trying to follow the rules. The bulletin was released a couple of weeks after that meeting. “The division is also exploring additional modifications to its testing and screening protocols to detect” illicit products and banned methods, and it may require additional lab testing “of products throughout the supply chain as needed,” the agency’s bulletin stated. This article was produced for ProPublica’s Local Reporting Network in partnership with The Denver Gazette. Sign up for Dispatches to get stories in your inbox every week. Photo courtesy of WeedPornDaily. The post Colorado Marijuana Officials Announce Crackdown On Sales Of Hemp Products Amid ‘Risks To Public Safety’ appeared first on Marijuana Moment. View the live link on MarijuanaMoment.net

President Donald Trump on Saturday appeared to complain that federal officials are “slow-walking” following through on an executive order he issued to complete the process of federally rescheduling marijuana. “You’re going to get the rescheduling done, right, please? Will you get the rescheduling done, please?” Trump said, seeming to speak to a Department of Justice official during an event in the Oval Office on Saturday. “You know, they’re slow-walking me on rescheduling. You’re going to get it done, right?” The president did not specifically mention cannabis, and it’s not immediately clear who the official he was speaking to is, but it has been four months since he directed the attorney general to complete the process of moving marijuana from Schedule I of the Controlled Substances Act (CSA) to Schedule III “in the most expeditious manner.” That hasn’t yet occurred, however. The president’s comments came during a signing ceremony for a new executive order aimed at expanding and expediting research on the potential therapeutic benefits of psychedelics, a move aimed at making substances such as psilocybin, ibogaine, LSD and MDMA more readily available to patients in clinical settings. Longtime Trump advisor Roger Stone recently said someone in the Trump administration is “holding up” the completion of the cannabis rescheduling proposal. Trump this month fired Attorney General Pam Bondi, who opposed marijuana reform in Florida when she was that state’s attorney general, although there is no indication that cannabis was at the center of the president’s frustration with her performance in his administration. Todd Blanche, who previously served as Trump’s personal attorney and as deputy attorney general, is serving as acting attorney general until Bondi’s replacement is confirmed for the position. During his Senate Judiciary Committee confirmation process, Blanche said in response to a written question about marijuana rescheduling that he would “give the matter careful consideration after conferring with all relevant stakeholders, including [Drug Enforcement Administration] personnel.” When asked about aligning federal and state marijuana laws, he said that “coordination between federal and state authorities is critically important” but that he had “not had the opportunity to study this particular issue.” “If confirmed, I will consult with the necessary stakeholders and give this matter careful consideration,” he said. The post Trump Complains DOJ Is ‘Slow-Walking’ Marijuana Rescheduling, Four Months After He Issued An Order To Get It Done appeared first on Marijuana Moment. View the live link on MarijuanaMoment.net

President Donald Trump has signed an executive order aimed at expanding and expediting research on the potential therapeutic benefits of psychedelics, a move aimed at making substances such as psilocybin, ibogaine, LSD and MDMA more readily available to patients in clinical settings. The move will “dramatically accelerate access to new medical research and treatments based on psychedelic drugs,” Trump said. The order, which the president signed in the Oval Office on Saturday alongside federal health officials, advocates and the podcaster Joe Rogan, directs the Food and Drug Administration (FDA) to issue new guidance for researchers on conducting clinical trials on psychedelics. “In many cases, these experimental treatments have shown life-changing potential for those suffering from severe mental illness and depression—including our cherished veterans,” Trump said. Steps taken under the order will “clear away unnecessary bureaucratic hurdles, improve data sharing among the FDA and the Department of Veterans Affairs, and facilitate fast rescheduling of any psychedelic drugs that become FDA approved,” the president said. Some psychedelics like psilocybin and MDMA have been designated with “breakthrough therapy” status, meaning that preliminary clinical evidence shows they can provide substantial improvement over existing therapies. Trump said his order will “expedite” the further review of such substances. Trump also announced that the federal government is making $50 million available to support state-level research on ibogaine and is “opening a pathway for the substance to be administered to desperately ill patients under the Right to Try law” that he signed during his first term in office. Health and Human Services (HHS) Secretary Robert F. Kennedy, Jr. said at the signing event that under the president’s order his department “will accelerate research, approval and access to new mental health treatments, including psychedelic therapies.” “We’re taking this decision, this decisive step, to confront one of the most urgent public health challenges facing our nation, the mental health crisis,” he said. “This executive order will remove legal impediments that block American researchers, scientists, physicians and clinicians from properly studying these medicines and, where appropriate, establishing protocols for their safe therapeutic use.” Thanks to the leadership of President Trump, under this historic Executive Order, @HHSGov will accelerate research, approval, and access to new mental health treatments, including psychedelic therapies such as ibogaine. pic.twitter.com/ZiUl5IaoBL — Secretary Kennedy (@SecKennedy) April 18, 2026 Kennedy also said health officials will coordinate with the Drug Enforcement Administration (DEA) and Department of Justice on “rescheduling reviews after successful Phase 3 trials” on psychedelics. The order says that “the Attorney General shall, in consultation with HHS, initiate and complete review of any product containing a Schedule I substance that has successfully completed Phase 3 clinical trials for a serious mental health disorder, so that rescheduling, if appropriate under 21 U.S.C. 811, may proceed as quickly as practicable for such specific products that are ultimately approved under section 505 of the Federal Food, Drug, and Cosmetic Act.” Food and Drug Administration Commissioner Marty Makary said that his agency will issue three national priority vouchers for psychedelics. “Under this new program in this administration, drugs can get approved in weeks—not a year or a year plus, but in weeks—if they are in line with our national priorities,” he said. Makary also announced “the first ibogaine investigational new drug clearance,” which he said will “pave the way for the first-ever human trials in the United States” on the psychedelic. HHS is confronting the mental health crisis: @US_FDA will prioritize therapies that have received Breakthrough Therapy designation Expanding the use of Right to Try Coordinate with the @DEAHQ and @TheJusticeDept to begin rescheduling reviews after successful Phase 3… pic.twitter.com/G4wKePKyd5 — HHS Rapid Response (@HHSResponse) April 18, 2026 Rep. Morgan Luttrell (R-TX), who also attended the signing ceremony, said in a statement that he “can personally attest to the significant benefits of this treatment.” “It changed my life, and I look forward to seeing the impact it will have on countless others,” he said. “We’re losing too many veterans. If this treatment gives us a chance to change that, then we owe it to them to pursue it. The President’s executive order brings us closer to a lasting solution that our veterans deserve.” Centers for Medicare & Medicaid Services Director Mehmet Oz called the president’s action “a paradigm shift for mental health treatment.” “Grateful to work alongside leaders who refuse to accept ‘no’ when lives are on the line,” he said. In a paradigm shift for mental health treatment, President Trump’s Executive Order fast-tracks access to psychedelic treatments for 14 million Americans in need. Momentum matters—credit to @joerogan for reigniting the conversation and to @SecKennedy for driving a… pic.twitter.com/ok0DnAcotV — Dr. Mehmet Oz (@DrOz) April 18, 2026 A growing body of research and experience indicates that psychedelics can help people suffering with post-traumatic stress disorder, traumatic brain injuries, drug addiction and other mental health disorders. Lawmakers in a number of states have passed legislation to support clinical trials with the aim of developing ibogaine into a legal medication with approval from the Food and Drug Administration (FDA). Texas officials, for example, recently announced that the state will move ahead with launching its own research program on the psychedelic after the they couldn’t find a company to lead a consortium on the issue under a bill enacted last year. The federal psychedelics move comes four months after Trump issued an executive order directing the Department of Justice to completed the process of moving marijuana from Schedule I of the CSA to Schedule III “in the most expeditious manner”—though that still hasn’t happened. Accelerating Medical Treatments for Serious Mental Illness@JoeRogan: "For 56 years we've lived under those terrible conditions. We're free of that now. Thanks to all these people… and thanks to President Trump." https://t.co/j1tkGACSM7 pic.twitter.com/aQmZl3z4PG — The White House (@WhiteHouse) April 18, 2026 Meanwhile, Kennedy said recently that the Trump administration is “very anxious” to create a pathway for access to psychedelics therapy and that top officials across federal agencies want to “get it out to the public as quickly as possible.” In an interview on the Joe Rogan Experience in February, Kennedy said he’s confident “we’re going to get it done,” with plans to develop and finalize rules that would enable patients with conditions such as post-traumatic stress disorder (PTSD) and depression to access psychedelic substances like psilocybin and MDMA in a “very controlled setting.” “Everybody in my agency…is very anxious to get a rule out there that will allow these kind of studies and will allow access under therapeutic settings, particularly [for] the military soldiers who have suffered these injuries to get access to these products,” the HHS secretary said. “We’re working through that process now. We’re all working on it and trying to make it happen.” “I think that we’re going to get it done,” he said. Last June, Kennedy said his agency is “absolutely committed” to expanding research on the benefits of psychedelic therapy and, alongside of the head of FDA, is aiming to provide legal access to such substances for military veterans “within 12 months.” Veterans Affairs Secretary Doug Collins also disclosed in April that he had an “eye-opening” talk with Kennedy about the therapeutic potential of psychedelic medicine. And he said he’s open to the idea of having the government provide vouchers to cover the costs of psychedelic therapy for veterans who receive services outside of VA as Congress considers pathways for access. Thank you, President Trump. We need an all-of-the-above strategy when it comes to tackling mental health, and your EO opens up new possibilities for America’s Veterans. https://t.co/OOqKuWd6C2 — VA Secretary Doug Collins (@SecVetAffairs) April 18, 2026 Bipartisan congressional lawmakers introduced legislation this session to provide $30 million in funding annually to establish psychedelic-focused “centers for excellence” at U.S. Department of Veterans Affairs (VA) facilities, where veterans could receive novel treatment involving substances like psilocybin, MDMA and ibogaine. Former U.S. House Speaker Newt Gingrich (R-GA) has said ibogaine represents an “astonishing breakthrough” in the nation’s current “sick care system” that’s left people with serious mental health conditions without access to promising alternative treatment options. The post Trump Signs Order To Accelerate Legal Access To Psychedelics For Patients With Mental Health Conditions appeared first on Marijuana Moment. View the live link on MarijuanaMoment.net

“The judge here is concerned about retailers that have made big investments in inventory, and they can’t move it, they can’t transport it, they can’t sell it.” By Megan Henry, Ohio Capital Journal A Franklin County judge granted a temporary restraining order (TRO) to allow two smoke shops to sell off their products less than a month after Ohio Senate Bill 56 took effect, which bans low-level THC hemp products and changes the state’s marijuana laws. Franklin County Court of Common Pleas Judge Jeffrey M. Brown issued a TRO Thursday allowing Happy Harvest locations and Get Wright Lounge to sell their existing products. Happy Harvest has locations in Delaware, Marion and Wood counties. Get Wright Lounge has one location in Columbus. “The judge here is concerned about retailers that have made big investments in inventory, and they can’t move it, they can’t transport it, they can’t sell it,” said Scott Pullins, the attorney for the plaintiffs. “He’s given them, really, a grace period that the legislature should give them.” Ohio S.B. 56 took effect March 20 after Ohioans for Cannabis Choice failed to get enough signatures to get a referendum on the November ballot for voters to block the law. Under the new law, THC levels in adult-use marijuana extracts will be reduced from a maximum of 90 percent down to a maximum of 70 percent, cap THC levels in adult-use flower to 35 percent, and prohibit smoking in most public places. The two businesses will only be able to sell products to people 21 and older, according to the Franklin County TRO. “Products obviously cannot resemble candy or anything along those lines,” Pullins said. He was not sure how much stock the stores had left. “If you haven’t gotten it out of state before the law goes into effect, you’re kind of stuck,” Pullins said. “You get caught transporting it, and they’re going to charge you with felony drug trafficking.” The new law prohibits possessing marijuana in anything outside of its original packaging, criminalizes bringing legal marijuana from another state back to Ohio, and requires drivers to store marijuana in the trunk of their car while driving. A preliminary injunction hearing will be scheduled in about two weeks, Pullins said. “We’ll come in and bring witnesses in, but we think we have a good shot at least being able to continue in business through November,” he said. New federal restrictions on hemp products are set to take effect November 12. Congress voted last November to ban products that contain 0.4 milligrams of total THC per container when they voted to reopen the government. Previously, the 2018 Farm Bill said hemp can be grown legally if it contains less than 0.3 percent THC. Ohio state Rep. Jennifer Gross, R-West Chester, recently joined the lawsuit as a plaintiff. She voted against Senate Bill 56 in November. “[She’s] someone that can testify to the legislative process, how it was handled,” Pullins said. “She’s been very supportive throughout the process.” A Sandusky County judge recently issued TRO on the hemp portion of the new law which allows the sale of intoxicating hemp products to continue in Fremont. This story was first published by Ohio Capital Journal. The post Ohio Judge Temporarily Pauses Hemp Product Ban For Two Businesses appeared first on Marijuana Moment. View the live link on MarijuanaMoment.net

Our agency focuses on making the process simple and stress-free. When exploring Escorts Subhash Nagar, we advise clients to take their time and choose wisely. This ensures better compatibility and creates a more natural and enjoyable connection.

i love reading this article so beautiful!!great job! 오피스타

You know your projects stand out of the herd. There is something special about them. It seems to me all of them are really brilliant! 오피스타

Its a great pleasure reading your post.Its full of information I am looking for and I love to post a comment that "The content of your post is awesome" Great work. 오피스타 I recently came across your blog and have been reading along. I thought I would leave my first comment. I don't know what to say except that I have enjoyed reading. Nice blog. I will keep visiting this blog very often. THCA Flower